The future of molecular imaging in paradigm shift from reactive to proactive (P4) medicine: Predictive, preventive, personalized and participatory

摘要

Introduction: Over the past few decades medicine has been changing rapidly. For a long time the medical field relied primarily on evidence-based medicine, which focused on data from clinical trials [1]. In contrast, the medicine of the future will be based on presymptomatic indicators, a wellness-maintenance system, several measurements — including different numbers of 'OMICs', e.g. genomics, proteomics - individual-centric needs, the social networking of patients, and the genotype and phenotype of diseases [1].